InvestorsHub Logo
Followers 116
Posts 1877
Boards Moderated 0
Alias Born 11/22/2017

Re: Lykiri post# 215055

Tuesday, 02/19/2019 1:03:57 PM

Tuesday, February 19, 2019 1:03:57 PM

Post# of 700658
Comments on twitter from Sean Sachdev, MD on Lomustine-temozolomide study.

I recall presented at SNO2017. Some issues: small numbers ~130 pts & imbalance; survival estimate comes from a stratified analysis & they used "inverse probability weights." With the pure unstratified analysis 31.4/37.9 (p=0.66) not statistically significant. Intriguing though.



https://pbs.twimg.com/media/DztPS9tWsAEqkqD.jpg

Sean Sachdev, MD @SeanSachdevMD
Radiation Oncologist, brain & spine, GU specialist. Assistant Professor at @NorthwesternMed @LurieCancer. #radonc #btsm #pcsm tweets = own opinion
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News